Breathe Well Live Well
|
BRIEF-Japan approves GlaxoSmithkline's asthma drug Nucala
Reuters March 29 Glaxosmithkline Plc. * Receives marketing authorisation for nucala (mepolizumab) in Japan. * Nucala is licensed in japan for adults and adolescents aged 12 years or older Source text for Eikon: Further company coverage: (Reporting By London … |
View full post on asthma – Google News
Philadelphia Business Journal |
Research group questions price of GlaxoSmithKline's new asthma drug
Philadelphia Business Journal The Institute for Clinical and Economic Review, a Boston-based nonprofit research organization that studies the effectiveness and value of drugs, issued a draft report Monday that said the price of GlaxoSmithKline's new asthma medicine Nucala should be … Independent group says new Glaxo asthma drug far too expensive |
View full post on asthma – Google News
Medscape |
GlaxoSmithKline's new asthma drug gets a split vote from FDA advisers
FierceBiotech GSK's injection, mepolizumab, works by blocking the protein interleukin-5 to prevent buildups of white blood cells in the lungs that can exacerbate asthma. The company is angling to get the drug approved as a treatment for sufferers of severe asthma … FDA Panel Backs Mepolizumab for Severe Eosinophilic Asthma GlaxoSmithKline plc (ADR) Wins FDA Panel Backing For Severe Asthma Drug Asthma Drug Targeting IL-5 Wins Partial Backing From FDA Advisers |
View full post on asthma – Google News
|
FDA approves GlaxoSmithKline's Arnuity Ellipta for treatment of asthma
News-Medical.net GlaxoSmithKline plc today announced that the FDA has approved Arnuity™ Ellipta® (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for maintenance treatment of asthma as prophylactic therapy in patients aged 12 … |
View full post on asthma – Google News
|
GlaxoSmithKline's asthma med among top-selling drugs in U.S.
Triangle Business Journal (blog) The British drug company, which has its North American headquarters in Research Triangle Park, comes in fifth with asthma medicine Advair Diskus. The rest of the top five: Otsuka Pharmaceuticals' Abilify. AstraZeneca Pharmaceuticals' (NYSE: AZN) Nexium … |
View full post on asthma – Google News
|
Asthma preventive drugs market led by GlaxoSmithKline's Advair
The Pharma Letter Asthma is a respiratory condition in which the airways become inflamed and constrict, usually in response to one or more environmental triggers. As a serious and potentially fatal condition if left untreated, asthma can be managed by avoiding triggers … |
View full post on asthma – Google News